StoxAster DM Quality Care vs Abbott India: share price & financials comparison
NSE: ASTERDM vs ABBOTINDIA · Healthcare · as of 13 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Aster DM Quality Care vs Abbott India at a glance
Aster DM Quality Care (ASTERDM) has a market capitalisation of ₹62,979 Cr, against ₹56,185 Cr for Abbott India (ABBOTINDIA). Over the past year Aster DM Quality Care has returned +4.9%, compared with -9.9% for Abbott India. On valuation, Abbott India trades at a lower P/E of 34.8 versus 133.8. Aster DM Quality Care comes out ahead on growth, momentum and technicals. Abbott India comes out ahead on valuation and profitability. Across the scored metrics below, Aster DM Quality Care leads on 7 and Abbott India on 4. On StoxGud's 10-point checklist, Aster DM Quality Care scores 5/10 and Abbott India scores 5/10.
| Metric | Aster DM Quality Care | Abbott India |
|---|---|---|
| Size | ||
| Market cap | ₹62,979 Cr | ₹56,185 Cr |
| Revenue (latest FY) | ₹4,643 Cr | — |
| Net profit (latest FY) | ₹388 Cr | — |
| Valuation | ||
| P/E | 133.8 | 34.8 |
| P/B | 8.08 | — |
| Dividend yield | 0.09% | — |
| Profitability | ||
| Return on equity | 6.0% | — |
| Net profit margin | 7.2% | 23.1% |
| Operating margin | 21.1% | 28.1% |
| Growth | ||
| Revenue growth (YoY) | +136.3% | +4.3% |
| Net profit growth (YoY) | +138.2% | +17.1% |
| Revenue CAGR (multi-year) | -11.6% | — |
| Financial health | ||
| Debt to equity | 0.51 | — |
| Momentum | ||
| 1-month return | +4.7% | +2.9% |
| 1-year return | +4.9% | -9.9% |
| 3-year CAGR | +28.3% | +4.5% |
| 5-year CAGR | +28.4% | +5.8% |
| 10-year CAGR | — | +19.3% |
| Distance from 52W high | -16.9% | -12.5% |
| Technicals | ||
| RSI (14) | 76 | 62 |
| Price vs 200-day avg | +0.5% | -0.6% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Aster DM Quality Care | Abbott India |
|---|---|---|
| Price above 50-day average | ✓ | ✓ |
| Price above 200-day average | ✓ | ✗ |
| 50-day average above 200-day (uptrend) | ✗ | ✗ |
| RSI in healthy 40–70 zone | ✗ | ✓ |
| Positive 1-year return | ✓ | ✗ |
| Return on equity above 15% | ✗ | ✗ |
| Debt to equity below 1 | ✓ | ✗ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✗ | ✓ |
| P/E below industry median | ✗ | ✓ |
| Score | 5/10 | 5/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Aster DM Quality Care or Abbott India?
Aster DM Quality Care has a market cap of ₹62,979 Cr and Abbott India has a market cap of ₹56,185 Cr as of 13 Nov 2026.
Which has a lower P/E, Aster DM Quality Care or Abbott India?
Abbott India has the lower P/E: Aster DM Quality Care trades at 133.8 and Abbott India at 34.8.
Which gave better returns in the last year, Aster DM Quality Care or Abbott India?
Aster DM Quality Care did better: Aster DM Quality Care returned +4.9% and Abbott India returned -9.9% over one year.
What is the difference between Aster DM Quality Care and Abbott India?
Both are NSE-listed companies in Healthcare. They are about the same size by market cap (₹62,979 Cr vs ₹56,185 Cr). Operating margin is 21.1% for Aster DM Quality Care and 28.1% for Abbott India.
Which is better, Aster DM Quality Care or Abbott India?
It depends on what you are looking for, and StoxGud does not recommend either stock. On the metrics compared above, Aster DM Quality Care leads on 7 and Abbott India on 4. Aster DM Quality Care is ahead on growth, momentum and technicals. Abbott India is ahead on valuation and profitability. On StoxGud's rules-based checklist Aster DM Quality Care scores 5/10 and Abbott India scores 5/10. This is information, not advice: consult a SEBI-registered adviser before investing.